Fig. 6From: Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modificationThe effect of ZNF132 methylation on prognosis and clinicopathological features. a The high methylation level of ZNF132 was negatively correlated with overall survival in BC patients. b UALCAN was used to evaluate the impact of aberrant methylation on the clinicopathological features of BC patientsBack to article page